Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;49(5):1479-1488.
doi: 10.1007/s00261-024-04264-1. Epub 2024 Mar 29.

Differentiation of confluent hepatic fibrosis and infiltrative hepatocellular carcinoma on MR imaging

Jing-Jing Liu  1 , Meng-Jiao Duan  2 , Meng-Yue Huang  2 , Meng-Na Huang  2 , Meng-Zhu Wang  3 , Yong Zhang  2 , Jing-Liang Cheng  2
Affiliations

Differentiation of confluent hepatic fibrosis and infiltrative hepatocellular carcinoma on MR imaging

Jing-Jing Liu et al. Abdom Radiol (NY). 2024 May.

Abstract

Background: To identify reliable magnetic resonance imaging (MRI) features that can differentiate confluent fibrosis (CF) from infiltrative hepatocellular carcinoma (HCC).

Methods: A retrospective analysis was conducted on Twenty CF patients and 28 infiltrative HCC patients who underwent upper abdomen MRI scans. The imaging features of lesions were analyzed, and the apparent diffusion coefficient (ADC) of lesions were measured. Accuracy, sensitivity and specificity for the diagnosis of CF were calculated for each category individually and combined.

Results: Compared to infiltrative HCC, hepatic capsular retraction at the site of lesion, hepatic volume loss at the site of lesion and "nodular surround sign" were more common in patients with CF (all P < 0.001). Hepatic volume loss at the site of lesion, no or mild enhancement in arterial phase, and hyper-enhancing in delayed phase to the background parenchyma showed superior diagnostic accuracy (83.3%, 85.4%, 97.9%, respectively). When the lesion exhibited hepatic volume loss at the site of lesion or no or mild enhancement in arterial phase or hyper-enhancing in delayed phase, a sensitivity of 100.0% for the diagnosis of CF was achieved. When the lesion was positive for any two of three categories, or positive for all three categories, a specificity of 100.0% was achieved. The ADC values of CF were higher than those of infiltrative HCC (P < 0.001).

Conclusion: The combination of the hepatic volume loss at the site of lesion, no or mild enhancement in arterial phase, and hyper-enhancing in delayed phase to the background parenchyma can be considered reliable MR features for the diagnosis of CF, as they allow differentiation from infiltrative HCC.

Keywords: Confluent fibrosis; Hepatocellular carcinoma; Liver; Magnetic resonance imaging.

PubMed Disclaimer

References

    1. Ohtomo K, Baron RL, Dodd GD III, et al. (1993) Confluent hepatic fibrosis in advanced cirrhosis: appearance at CT. Radiology 188(1):31-35. - DOI - PubMed
    1. Ohtomo K, Baron RL, Dodd GD III, Federle MP, Ohtomo Y, Confer SR. (1993) Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging. Radiology 189(3):871-874. - DOI - PubMed
    1. Ozaki K, Matsui O, Gabata T, Kobayashi S, Koda W, Minami T. (2013) Confluent hepatic fibrosis in liver cirrhosis: possible relation with middle hepatic venous drainage. Jpn J Radiol 31(8):530-537. - DOI - PubMed
    1. Mwangi I, Hanna RF, Kased N, et al. (2010) Apparent diffusion coefficient of fibrosis and regenerative nodules in the cirrhotic liver at MRI. AJR Am J Roentgenol 194(6):1515-1522. - DOI - PubMed
    1. Brancatelli G, Baron RL, Peterson MS, Marsh W. (2003) Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: frequency and causes of false-positive interpretation. AJR Am J Roentgenol 180(4):1007-1014. - DOI - PubMed

Publication types

LinkOut - more resources